Core Stock Based Compensation from 2010 to 2024

CORZ Stock

USD 17.71 0.59 3.45%

Core Scientific, Stock Based Compensation yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2010-12-31

Previous Quarter

67.7 M

Current Value

78 M

Quarterly Volatility

50.2 M

Credit Downgrade

Yuan Drop

Covid

Check Core Scientific, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Core Scientific,'s main balance sheet or income statement drivers, such as Tax Provision of 645.4 K, Depreciation And Amortization of 116.5 M or Interest Expense of 63.8 M, as well as many indicators such as Price To Sales Ratio of 3.06, Dividend Yield of 0.0 or Days Sales Outstanding of 5.46. Core financial statements analysis is a perfect complement when working with Core Scientific, Valuation or Volatility modules.

Check out the analysis of Core Scientific, Correlation against competitors.

Latest Core Scientific,'s Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Core Scientific, Common over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Core Scientific,'s Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Core Scientific,'s overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Core Stock Based Compensation Regression Statistics

	Arithmetic Mean	30,456,853
	Geometric Mean	8,803,870
	Coefficient Of Variation	164.84
	Mean Deviation	36,559,804
	Median	3,037,000
	Standard Deviation	50,205,718
	Sample Variance	2520.6T
	Range	179.9M
	R-Value	0.64
	Mean Square Error	1594.1T
	R-Squared	0.41
	Significance	0.01
	Slope	7,212,553
	Total Sum of Squares	35288.6T

Core Stock Based Compensation History

	2024	78 M
	2023	67.7 M
	2022	58.9 M
	2021	182.9 M
	2020	38.9 M

Other Fundumenentals of Core Scientific, Common

Stock Based Compensation To Revenue

Core Scientific, Stock Based Compensation component correlations

	Long Term Debt	Good Will	Intangible Assets	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Short Term Investments
Long Term Debt		0.22	-0.23	0.67	-0.29	-0.2	0.87	-0.87	0.85	-0.33	0.98	0.26	0.9	0.36	0.97	-0.43	0.94	0.32	-0.61
Good Will	0.22		0.76	0.87	0.86	0.91	0.24	0.27	-0.21	0.67	0.19	0.97	0.08	0.99	0.16	0.74	0.09	0.99	0.16
Intangible Assets	-0.23	0.76		0.45	0.87	0.87	-0.09	0.63	-0.48	0.78	-0.31	0.75	-0.25	0.68	-0.34	0.79	-0.41	0.71	0.21
Total Assets	0.67	0.87	0.45		0.51	0.58	0.59	-0.24	0.25	0.3	0.63	0.85	0.49	0.93	0.61	0.35	0.54	0.91	-0.17
Total Stockholder Equity	-0.29	0.86	0.87	0.51		0.99	-0.23	0.71	-0.65	0.79	-0.32	0.8	-0.4	0.78	-0.35	0.96	-0.4	0.81	0.44
Current Deferred Revenue	-0.2	0.91	0.87	0.58	0.99		-0.12	0.64	-0.56	0.82	-0.23	0.87	-0.3	0.84	-0.25	0.92	-0.31	0.86	0.4
Net Debt	0.87	0.24	-0.09	0.59	-0.23	-0.12		-0.71	0.89	0.02	0.83	0.39	0.98	0.35	0.81	-0.47	0.76	0.32	-0.72
Retained Earnings	-0.87	0.27	0.63	-0.24	0.71	0.64	-0.71		-0.91	0.66	-0.88	0.22	-0.82	0.13	-0.9	0.78	-0.91	0.17	0.57
Accounts Payable	0.85	-0.21	-0.48	0.25	-0.65	-0.56	0.89	-0.91		-0.4	0.83	-0.07	0.96	-0.08	0.82	-0.8	0.81	-0.12	-0.78
Net Receivables	-0.33	0.67	0.78	0.3	0.79	0.82	0.02	0.66	-0.4		-0.34	0.76	-0.17	0.59	-0.39	0.64	-0.43	0.61	0.28
Total Liab	0.98	0.19	-0.31	0.63	-0.32	-0.23	0.83	-0.88	0.83	-0.34		0.22	0.87	0.33	1.0	-0.45	0.99	0.29	-0.49
Net Invested Capital	0.26	0.97	0.75	0.85	0.8	0.87	0.39	0.22	-0.07	0.76	0.22		0.22	0.96	0.19	0.62	0.11	0.97	0.04
Short Long Term Debt	0.9	0.08	-0.25	0.49	-0.4	-0.3	0.98	-0.82	0.96	-0.17	0.87	0.22		0.2	0.85	-0.61	0.82	0.16	-0.76
Total Current Assets	0.36	0.99	0.68	0.93	0.78	0.84	0.35	0.13	-0.08	0.59	0.33	0.96	0.2		0.3	0.64	0.23	1.0	0.08
Capital Stock	0.97	0.16	-0.34	0.61	-0.35	-0.25	0.81	-0.9	0.82	-0.39	1.0	0.19	0.85	0.3		-0.47	0.99	0.26	-0.48
Net Working Capital	-0.43	0.74	0.79	0.35	0.96	0.92	-0.47	0.78	-0.8	0.64	-0.45	0.62	-0.61	0.64	-0.47		-0.51	0.67	0.56
Short Term Debt	0.94	0.09	-0.41	0.54	-0.4	-0.31	0.76	-0.91	0.81	-0.43	0.99	0.11	0.82	0.23	0.99	-0.51		0.19	-0.42
Common Stock	0.32	0.99	0.71	0.91	0.81	0.86	0.32	0.17	-0.12	0.61	0.29	0.97	0.16	1.0	0.26	0.67	0.19		0.1
Short Term Investments	-0.61	0.16	0.21	-0.17	0.44	0.4	-0.72	0.57	-0.78	0.28	-0.49	0.04	-0.76	0.08	-0.48	0.56	-0.42	0.1

Click cells to compare fundamentals

About Core Scientific, Financial Statements

Core Scientific, investors use historical fundamental indicators, such as Core Scientific,'s Stock Based Compensation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Core Scientific,. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Stock Based Compensation	67.7 M	78 M
Stock Based Compensation To Revenue	0.12	0.09

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Core Stock Analysis

When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Core Stock Based Compensation from 2010 to 2024

Latest Core Scientific,'s Stock Based Compensation Growth Pattern

Core Stock Based Compensation Regression Statistics

Core Stock Based Compensation History

Other Fundumenentals of Core Scientific, Common

Core Scientific, Stock Based Compensation component correlations

About Core Scientific, Financial Statements

Also Currently Popular

Additional Tools for Core Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY